Organic Process Research & Development 2007, 11, 422−430
Scale-Up Syntheses of Two Naturally Occurring Procyanidins:
(-)-Epicatechin-(4â,8)-(+)-catechin and
(-)-Epicatechin-3-O-galloyl-(4â,8)-(-)-epicatechin-3-O-gallate†
Pradeep K. Sharma,‡ Alexander Kolchinski,‡ He´le`ne A. Shea,§ Jayesh J. Nair,§ Yanni Gou,| Leo J. Romanczyk, Jr.,*, and
Harold H. Schmitz#
Chemical Process Research & DeVelopment, Catalytic SerVices, and Analytical DiVision, Johnson Matthey
Pharmaceutical Materials, Inc., 25 Patton Road, DeVens, Massachusetts 01434, U.S.A., Masterfoods USA, A MARS
Incorporated Company, 800 High Street, Hackettstown, New Jersey 07840, U.S.A., and MARS, Incorporated,
6885 Elm Street, McLean, Virginia 22101, U.S.A.
Abstract:
Our interest is focused mainly at the cancer and vascular
biology areas, where initial observations have shown different
procyanidins to evoke different activities.10-23 To unequivo-
cally determine the natural oligomeric procyanidins associ-
ated with these activities and to confirm the structures
assigned to these compounds, a synthesis program was
initiated.24-27 A series of oligomers of defined regio- and
stereochemistry were synthesized for comparison to oligo-
mers purified from cocoa extracts for structure-activity
A scaleable process for the synthesis of two naturally occurring
procyanidins, namely (-)-epicatechin-(4â,8)-(+)-catechin (1)
and (-)-epicatechin-3-O-galloyl-(4â,8)-(-)-epicatechin-3-O-gal-
late (2), is described. The key steps were highlighted by
improvements for the benzylation of (+)-catechin (3), stereo-
selective reduction of the C-3 keto group of (2R)-5,7,3′,4′-
tetrakis(benzyloxy)flavan-3-one (10), and coupling between
4-hydroxyethoxy-5,7,3′,4′-tetra-O-benzyl-(-)-epicatechin (11)
and 5,7,3′,4′-tetra-O-benzyl-(+)-catechin (4) or 5,7,3′,4′-tetra-
O-benzyl-(-)-epicatechin (6), respectively. The debenzylation
performed in a biphasic system resulted in an improved yield
and purity of the target compounds. The chemistry was scaled-
up to produce multigram quantities of the title compounds (1
and 2) for various in Witro, ex WiWo, and in WiWo studies.
Moreover, the scale-up process provided a detailed description
for the preparation of multihundred to kilogram scale quantities
of intermediates used in the synthesis of these two titled
procyanidins.
(3) Saito, M.; Hosoyama, H.; Ariga, T.; Kataoka, S.; Yamaji, N. J. Agric. Food.
Chem. 1998, 46, 1460.
(4) (a) Liviero, L.; Puglisis, P. P.; Morazzoni, P.; Bombardelli, E.
Fitoterapia 1994, 65, 203. (b) Constable, A.; Varga, N.; Richoz, J.;
Stadler, R. H. Mutagenesis 1996, 11, 189. (c) Inanami, O.; Watanabe,
Y.; Syuto, B.; Nakano, M.; Kuwabara, M. Free Radical Res. 1998,
29, 359.
(5) Inanami, O.; Watanabe, Y.; Syuto, B.; Nakano, M.; Kuwabara, M. Free
Radical Res. 1998, 29, 359.
(6) Hartisch, C.; Kolodziej, H.; Von Bruchhausen, F. Planta Med. 1977, 63,
106.
(7) Scalbert, A. Phytochemistry 1991, 30, 3875.
(8) Kameda, K.; Takau, T.; Okuda, H.; Kimura, Y.; Okuda, T.; Hatano, T.;
Agata, I.; Arichi, S. J. Nat. Prod. 1987, 50, 680.
(9) (a) So, F. V.; Guthrie, N.; Chambers, A. F.; Carroll, K. K. Cancer Lett.
1997, 112, 127 and references cited therein. (b) Kolodziej, H.; Haberland,
C.; Woerdenbag, H.; Konigs, A. W. T. Phytotherapy Res. 1995, 9, 410. (c)
Ramljak, D.; Romanczyk, L. J.; Metheny-Barlow, L. J.; Thompson, N.;
Knezevic, V.; Galaperin, M.; Ramesh, A.; Dickson, R. B. Mol. Cancer Ther.
2005, 4, 537.
(10) Romanczyk, L. J., Jr.; Hammerstone, J. F., Jr.; Buck, M. M. U.S. Patent
5,712,305, January 27, 1998.
(11) Romanczyk, L. J., Jr.; Hammerstone, J. F., Jr.; Buck, M. M.;
Post, L. S.; Cipolla, G. G.; McClelland, C. A.; Mundt, J. A.;
Schmitz, H. H. PCT Int. Appl. WO 9736597. Chem. Abstracts 1997, 127,
322787.
(12) Romanczyk, L. J., Jr.; Hammerstone, J. F., Jr.; Buck, M. M. U.S. Patent
5,554,645, September 10, 1996.
(13) Romanczyk, L. J., Jr.; Hammerstone, J. F., Jr.; Buck, M. M.;
Post, L. S.; Cipolla, G. G.; McClelland, C. A.; Mundt, J. A.;
Schmitz, H. H. PCT Int. Appl. WO 9736,497. Chem. Abstracts 1997, 127,
330680.
(14) Kenny, T. P.; Keen, C. L.; Jones, P.; Kung, H. J.; Schmitz, H. H.; Gershwin,
M. E. Exp. Biol. Med. (Maywood) 2004, 229, 765.
(15) Engler, M. B.; Engler, M. M.; Chen, C. Y.; Malloy, M. J.;
Browne, A.; Chiu, E. Y.; Kwak, H. K.; Milbury, P.; Paul,
S. M.; Blumberg, J.; Mietus-Synder, M. L. J. Am. Coll. Nutr. 2004, 23,
197.
Introduction
Polyphenols are an important class of natural products.
Such compounds are widely distributed in nature and possess
a diverse range of biological activities. These include, but
are not limited to, the inhibition of HIV 1 replication in Vitro,1
reducing the risk of heart disease,2 suppressing ulcer forma-
tion,3 possessing antimutagenic,4 neuroprotective,5 anti-
inflammatory,6 antibacterial,7 and hypotensive8 properties,
and can inhibit the growth of cancer cells.9
* To whom correspondence should be addressed. E-mail: leo.romanczyk@
mss.effem.com. Telephone: (908) 892-1125. Fax: (908) 892-1196.
† Part of this work has been incorporated in patent application WO2007005248
and US2007004796(A1).
‡ Chemical Process Research & Development, Johnson Matthey Pharmaceuti-
cal Materials, Inc.
§ Catalytic Services, Johnson Matthey Pharmaceutical Materials, Inc.
| Analytical Division, Johnson Matthey Pharmaceutical Materials, Inc.
Masterfoods USA.
(16) Kenny, T. P.; Keen, C. L.; Jones, P.; Kung, H. J.; Schmitz, H. H.; Gershwin,
M. E. Exp. Biol. Med. (Maywood) 2004, 229, 255.
(17) Maron, D. J. Curr. Atheroscler. Rep. 2004, 6, 73.
(18) Fischer, N. D.; Hughes, M.; Gerhard-Herman, M.; Hollenberg, N. K. J.
Hypertersion 2003, 21, 2281.
(19) Pearson, D. A.; Paglieroni, H. G.; Rein, D.; Wun, T.; Schramm, D. D.;
Wang, J.; Holt, R. R.; Gosselin, R.; Schmitz, H. H.; Keen, C. L. Throm.
Res. 2004, 15, 191.
# MARS, Incorporated.
(1) Shahat, A. A.; Ismail, S. I.; Hammouda, F. M.; Azzam, S. A.; Lemiere, G.;
De Bruyne, T.; De Swaet, S.; Piteters, L.; Vlietinck, A. Phytomedicine 1998,
5, 133.
(2) (a) Aviram, M.; Fuhrman, B. Artherosclerosis 1998, 137, S45. (b)Yama-
koshi, J.; Kataoka, S.; Koga, T.; Ariga, T. Artherosclerosis 1999, 142, 139.
422
•
Vol. 11, No. 3, 2007 / Organic Process Research & Development
10.1021/op700031n CCC: $37.00 © 2007 American Chemical Society
Published on Web 04/26/2007